Lv1
36 积分 2024-08-15 加入
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
5个月前
已完结
Development of [225Ac]Ac‑LNC1011 for targeted alpha-radionuclide therapy of prostate cancer
5个月前
已完结
FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy
6个月前
已完结
FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy
6个月前
已完结
皖公网安备34019202002308
